The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.
08/03/2016 | Managing Intellectual Property Blog
Approval Biosimilar Notice Implicates Millions
1 min
Related Services
Related Insights
Nike StockX Battle Heats Up
Nike StockX Battle Heats Up
May 17, 2022
3min
Digital Good v. Digital Receipt: The Dispute Over StockX's Use of Nike Trademarks in NFTs
Digital Good v. Digital Receipt: The Dispute Over StockX's Use of Nike Trademarks in NFTs
May 09, 2022
4min
Will the Western District of Texas Remain a Busy Patent Venue Despite Transfers
Will the Western District of Texas Remain a Busy Patent Venue Despite Transfers
April 20, 2022
2min
Events
Patent Eligibility, Prior Art, Obviousness and Disclosure 2022: Current Trends in Sections 101, 102, 103 and 112
Patent Eligibility, Prior Art, Obviousness and Disclosure 2022: Current Trends in Sections 101, 102, 103 and 112
May 23, 2022 the Practising Law Institute
Your Legal Guide to NFTs, the Metaverse, and Web3
Your Legal Guide to NFTs, the Metaverse, and Web3
June 14 – 16, 2022 | 1:00 – 2:00 p.m. ET Venable LLP
Recent News
Law360 Features Q&A with Bryan Rakes on His New Role as Business Division Co-Chair
Law360 Features Q&A with Bryan Rakes on His New Role as Business Division Co-Chair
May 20, 2022
1min
Belinda Vega Recognized Among Los Angeles Business Journal’s Top 100 Lawyers and Daily Journal’s Top Women Lawyers of 2022
Belinda Vega Recognized Among Los Angeles Business Journal’s Top 100 Lawyers and Daily Journal’s Top Women Lawyers of 2022
May 18, 2022
2min
Bloomberg Law Quotes Elizabeth Manno on the Findings of NAWL’s Annual Survey on the Promotion and Retention of Women in Law Firms
Bloomberg Law Quotes Elizabeth Manno on the Findings of NAWL’s Annual Survey on the Promotion and Retention of Women in Law Firms
May 17, 2022
2min